首页 | 本学科首页   官方微博 | 高级检索  
     

头孢哌酮/舒巴坦治疗重症肺炎的疗效观察
引用本文:刘绍霞,李金红. 头孢哌酮/舒巴坦治疗重症肺炎的疗效观察[J]. 中华医院感染学杂志, 2011, 21(24): 5266-5268
作者姓名:刘绍霞  李金红
作者单位:郑州大学第一附属医院呼吸内科,河南郑州,450052
摘    要:目的 评价头孢哌酮/舒巴坦治疗重症肺炎的疗效及安全性.方法 对2010年4月-2011年4月医院住院的36例重症肺炎患者,应用头孢哌酮/舒巴坦,1次/6 h,静脉滴注,疗程7~14 d,观察治疗前及治疗后的临床症状及体征、影像学表现、治疗时间、临床疗效、细菌学疗效和不良反应.结果 36例患者经头孢哌酮/舒巴坦治疗后临床有效率为83.34%,不良反应发生率为5.56%.结论 头孢哌酮/舒巴坦治疗重症肺炎是安全有效的.

关 键 词:头孢哌酮/舒巴坦  重症肺炎  疗效观察

Efficacy and safety of cefoperazone/sulbactam in treatment of severe pneumonia
LIU Shao-xia , LI Jin-hong. Efficacy and safety of cefoperazone/sulbactam in treatment of severe pneumonia[J]. Chinese Journal of Nosocomiology, 2011, 21(24): 5266-5268
Authors:LIU Shao-xia    LI Jin-hong
Affiliation:LIU Shao-xia,LI Jin-hong (First Affiliated Hospital,Zhengzhou University,Zhengzhou,Henan 450052,China)
Abstract:OBJECTIVE To estimate the efficiency and safety of cefoperazone/sulbactam in treatment of patients with severe pneumonia. METHODS A total of 36 patients with severe pneumonia,who were diagnosed in our hospital during Apr 2010-Apr 2011,were given cefoperazone sodium and sulbactam sodium 3.0g q6h by iv for 7-14 days.Then the clinical manifestations,physical sign,imaging appearances,the time required for therapy,the clinical effects,the bacterial clearance rate and adverse reactions before and after the treatm...
Keywords:Cefoperazone/sulbactam  Severe pneumonia  Efficacy observation  
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号